Microscopic polyangiitis laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 18: Line 18:
* leukocytosis.
* leukocytosis.


===Urianlysis<ref name="pmid100887632">{{cite journal |vauthors=Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B |title=Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients |journal=Arthritis Rheum. |volume=42 |issue=3 |pages=421–30 |date=March 1999 |pmid=10088763 |doi=10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6 |url=}}</ref>===
===Urinalysis<ref name="pmid100887632">{{cite journal |vauthors=Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B |title=Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients |journal=Arthritis Rheum. |volume=42 |issue=3 |pages=421–30 |date=March 1999 |pmid=10088763 |doi=10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6 |url=}}</ref>===
* Proteinuria
* Proteinuria
* Hematuria
* Hematuria

Revision as of 19:10, 23 April 2018

Microscopic polyangiitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Microscopic polyangiitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Radiation therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Microscopic polyangiitis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Microscopic polyangiitis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Microscopic polyangiitis laboratory findings

CDC on Microscopic polyangiitis laboratory findings

Microscopic polyangiitis laboratory findings in the news

Blogs on Microscopic polyangiitis laboratory findings

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Microscopic polyangiitis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]Vamsikrishna Gunnam M.B.B.S [4]

Overview

When suspecting a patient with microscopic polyangiitis(MPO) an ANCA test should be an idle choice.Laboratory findings consistent with the diagnosis of Microscopic polyangiitis include leukocytosis, elevated erythrocyte sedimentation rate, proteinuria, hematuria, red cell casts, elevated blood urea nitrogen, elevated serum creatinine, and anti-neutrophil cytoplasmic antibodies.

Laboratory Findings

Laboratory findings consistent with the diagnosis of Microscopic polyangiitis include, anti-neutrophil cytoplasmic antibody, elevated blood urea nitrogen, elevated serum creatinine, elevated erythrocyte sedimentation rate, proteinuria, hematuria, red cell casts, and leukocytosis.

Blood Work-up[1][2][3]

  • Anti-neutrophil cytoplasmic antibody test.
  • MPA is primarily associated with MPO-ANCA.[4]
  • Complete blood count.
  • Serum creatinine.
  • Blood urea nitrogen.
  • leukocytosis.

Urinalysis[5]

  • Proteinuria
  • Hematuria
  • Red cell casts

Biopsy

Biopsy of the involved skin, lung, renal, and nerve can be made to help establish a diagnosis of Microscopic polyangiitis.[6][7]

  • Skin biopsy is characterized by the presences of immunoglobulins and complement components.
  • Renal biopsy is characterized as a crescent formation with focal necrosis.
  • Lung biopsy is characterized by alveolar capillaritis.
  • Nerve biopsy is characterized by vascular necrosis of small and medium-sized vessels.

References

  1. Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B (March 1999). "Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients". Arthritis Rheum. 42 (3): 421–30. doi:10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6. PMID 10088763.
  2. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, Lesavre P, Lüdemann J, Rasmussen N, Sinico RA, Wiik A, van der Woude FJ (March 1998). "Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization". Kidney Int. 53 (3): 743–53. doi:10.1046/j.1523-1755.1998.00807.x. PMID 9507222.
  3. Lhote F, Cohen P, Généreau T, Gayraud M, Guillevin L (1996). "Microscopic polyangiitis: clinical aspects and treatment". Ann Med Interne (Paris). 147 (3): 165–77. PMID 8796093.
  4. Savige J, Pollock W, Trevisin M (April 2005). "What do antineutrophil cytoplasmic antibodies (ANCA) tell us?". Best Pract Res Clin Rheumatol. 19 (2): 263–76. doi:10.1016/j.berh.2004.10.003. PMID 15857795.
  5. Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B (March 1999). "Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients". Arthritis Rheum. 42 (3): 421–30. doi:10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6. PMID 10088763.
  6. Schnabel A, Holl-Ulrich K, Dalhoff K, Reuter M, Gross WL (December 1997). "Efficacy of transbronchial biopsy in pulmonary vaculitides". Eur. Respir. J. 10 (12): 2738–43. PMID 9493653.
  7. Lauque D, Cadranel J, Lazor R, Pourrat J, Ronco P, Guillevin L, Cordier JF (July 2000). "Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P)". Medicine (Baltimore). 79 (4): 222–33. PMID 10941351.

Template:WH Template:WS